Clinuvel Pharmaceuticals Limited Sponsored ADR (CUVL) Live Share Price, Invest From India

Clinuvel Pharmaceuticals Limited Sponsored ADR Stock Performance

as on September 5, 2026 at 2:16 pm IST

Day's Low
Day's High
$6.12
Day's Price Range
$6.73
$6.52
6.13%
Downside
3.22%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$6.52
100.00%
Downside
-100.00%
Upside

Clinuvel Pharmaceuticals Limited Sponsored ADR share price movements today

Previous Close: $6.28
Open: $6.28
Volume: 192.4K
Market Cap: $297.7M
Dividend Yield: 41.85%
Day's Low - High: $6.12 - $6.73

Clinuvel Pharmaceuticals Limited Sponsored ADR Historical Returns

1 Month Return: -8.19 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Clinuvel Pharmaceuticals Limited Sponsored ADR Stock Fundamentals & Key Indicators

Check Clinuvel Pharmaceuticals Limited Sponsored ADR market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$297.7M

EPS (TTM)

Dividend Yield

41.85%

PE Ratio (TTM)

13.19

PEG Ratio

Return On Equity TTM

13.21%

Clinuvel Pharmaceuticals Limited Sponsored ADR vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Clinuvel Pharmaceuticals Limited Sponsored ADR with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Clinuvel Pharmaceuticals Limited Sponsored ADR	NA	$297.7M	NA	13.19	36.07%	41.85%
Revolution Medicines	BUY	$44.6B	614.61%	NA	0.00%	NA
Vertex Pharmaceuticals	BUY	$141.1B	181.73%	32.21	86.04%	NA
Moderna	BUY	$60.2B	-64.27%	-18.66	-12.57%	NA
Regeneron	BUY	$84.8B	24.12%	20.14	84.86%	0.44%

Indian Investors' Interest in Clinuvel Pharmaceuticals Limited Sponsored ADR Stock

Search interest for Clinuvel Pharmaceuticals Limited Sponsored ADR Stock has increased by 490% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 6, 2026 to September 5, 2026

Change:490% versus previous 30 day period

Clinuvel Pharmaceuticals Limited Sponsored ADR Annual Profit & Loss

All numbers in Millions USD

	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Total Revenue	46	52	58	95
Gross Profit	38	46	51	79
Operating Income	35	44	48	45
EBITDA	-	-	-	-
Interest Expense	2	3	4	4
Depreciation	0	0	1	1
Income Before Tax	34	45	50	51
Income Tax Expense	-	-	-	-
Net Income	14	20	23	36
Net Profit Margin	31.77%	39.08%	40.41%	38.07%

Clinuvel Pharmaceuticals Limited Sponsored ADR Annual Cash Flow

All numbers in Millions USD

	Jun 2023	Jun 2024	Jun 2025
Net Income	30	35	36
Operating Cash Flow	-	-	-
Investing Cash Flow	-	-	-
Financing Cash Flow	-2	-3	-2
Change in Cash	33	4	-9

Insights on Clinuvel Pharmaceuticals Limited Sponsored ADR

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, CUVL stock has moved up by 5.8%

About Clinuvel Pharmaceuticals Limited Sponsored ADR

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and delivering therapies for patients with genetic, metabolic, and dermatological disorders in Australia, Ireland, the United States, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone; and PRÉNUMBRA, a liquid injectable formulation of afamelanotide. It is also developing NEURACTHEL (ACTH), an adrenocorticotropic hormone for targeting neurological, endocrinological, and degenerative disorders; SCENESSE and other formulations of afamelanotide to treat severe disorders, including vitiligo and porphyrias; and pharmaceutical formulations melanocortin technology for the treatment of a range of disorders. In addition, the company provides photocosmetic products for individuals and populations at risk of exposure to ultraviolet and high energy visible light, and in need of assistance in DNA repair and melanogenesis of the skin. The company was incorporated in 1999 and is headquartered in Melbourne, Australia.

Organisation	Clinuvel Pharmaceuticals Limited Sponsored ADR
Headquarters	535 Bourke Street, Melbourne, VIC, Australia, 3000
Industry	Biotechnology
CEO	Dr. Philippe Jacques Wolgen M.B.A., M.D.
E-voting on shares	Click here to vote

Key Management of Clinuvel Pharmaceuticals Limited Sponsored ADR

Name	Title
Dr. Linda Teng	Director of North American Operations
Dr. Emilie Rodenburger	Director of Global Clinical Affairs
Dr. Philippe Jacques Wolgen M.B.A., M.D.	CEO, MD & Director
Dr. Dennis J. Wright BPharm, M.Sc., Ph.D.	Chief Scientific Officer
Ms. Claire Newstead-Sinclair C.A.	Company Secretary
Dr. Azza Hamila	Head of Quality Assurance & Drug Safety
Mr. Peter Vaughan	Chief Financial Officer
Mr. Lachlan Hay	Chief Operations Officer
Mr. Malcolm Bull	Head of Australian Operations & Investor Relations

FAQs

What is Clinuvel Pharmaceuticals Limited Sponsored ADR share price today?

Clinuvel Pharmaceuticals Limited Sponsored ADR share price today is $6.52 as on September 5, 2026 at 8:46 am IST at the close of the market. Clinuvel Pharmaceuticals Limited Sponsored ADR share today touched a day high of $6.73 and a low of $6.12.

What is the 52 week high and 52 week low for Clinuvel Pharmaceuticals Limited Sponsored ADR share?

Clinuvel Pharmaceuticals Limited Sponsored ADR share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. Clinuvel Pharmaceuticals Limited Sponsored ADR stock price today i.e. September 5, 2026 at 8:46 am IST is closed at $6.52,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Clinuvel Pharmaceuticals Limited Sponsored ADR's market capitalisation today?

Clinuvel Pharmaceuticals Limited Sponsored ADR market capitalisation is $0.00T as on September 5, 2026 at 8:46 am IST.

How to invest in Clinuvel Pharmaceuticals Limited Sponsored ADR Stock (CUVL) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Clinuvel Pharmaceuticals Limited Sponsored ADR on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Clinuvel Pharmaceuticals Limited Sponsored ADR Shares that will get you 0.2301 shares as per Clinuvel Pharmaceuticals Limited Sponsored ADR share price of $6.52 per share as on September 5, 2026 at 8:46 am IST.

What is the minimum amount required to buy Clinuvel Pharmaceuticals Limited Sponsored ADR Stock (CUVL) from India?

Indian investors can start investing in Clinuvel Pharmaceuticals Limited Sponsored ADR (CUVL) shares with as little as ₹94.49 or $1 (as of September 5, 2026 at 9:37 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹944.90 in Clinuvel Pharmaceuticals Limited Sponsored ADR stock (as per the Rupee-Dollar exchange rate as on September 5, 2026 at 9:37 pm IST). Based on Clinuvel Pharmaceuticals Limited Sponsored ADR share’s latest price of $6.52 as on September 5, 2026 at 8:46 am IST, you will get 1.5337 shares of Clinuvel Pharmaceuticals Limited Sponsored ADR. Learn more about fractional shares .